Treace Medical Concepts, Inc. (TMCI) Tops Q1 EPS by 3c ; Offers Guidance

Treace Medical Concepts, Inc. (NASDAQ: TMCI) reported Q1 EPS of ($0.28), $0.03 better than the analyst estimate of ($0.31). Revenue for the quarter came in at $47.2 million versus the consensus estimate of $45.86 million.

GUIDANCE:

Treace Medical Concepts, Inc. sees FY2026 revenue of $202-212 million, versus the consensus of $205.9 million.

For earnings history and earnings-related data on Treace Medical Concepts, Inc. (TMCI) click here.

You May Also Be Interested In

• Elevance Health Inc. (ELV) Tops Q2 EPS by 124c, raises guidance
• TD Cowen Upgrades Mattr Ltd (MATR:CN) to Buy (correction)
• Morgan Stanley on Lucid Group Inc. (LCID): 'we believe the company's new management team is keenly focused on strengthening the business'